Dissecting sophisticated molecular and signaling networks regulated by CXCL13-CXCR5 axis and how this chemokine-receptor controls dynamic interactions between TNBC/HCC cell and the TME will be critical to identify novel effectors and therapeutic targets for cancer treatment. Here, CXCR5 is linked to hepatocellular carcinoma.